. Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia. J Am Geriatr Soc. 2017 Sep;65(9):1969-1974. Epub 2017 Jun 7 PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. Actually the following statement is not quite correct per UDS protocol: 

    "Another limitation, acknowledged by Goldstein and colleagues, is that PPI usage data came from lengthy questionnaires filled out by the patients themselves, rather than pharmacy dispensing databases or physician records." 

    These data are not supposed to be the result of "lengthy questionnaires filled out by the patients themselves." The pharmacy data, as well as other data captured by the UDS, are supposed to be collected as part of the clinical interview, usually by clinic staff, nurse, or examining physician, and available records. If the patient appears cognitively impaired, the information may be obtained from the co-participant (study partner) interview and may be supplemented by available medical records.  It would be decidedly "off protocol" to hand a study subject a UDS packet, or medications data form, and ask them to complete it on their own.

    View all comments by Walter Kukull

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. New Study Disputes Claim That Heartburn Meds Raise Dementia Risk